Current Approved Targeted Therapy Drugs Used in Spesific Cancer Types

Creative Commons License

Özdemir M. N., Alğın Yapar E., Esentürk Güzel İ.

4. International Cancer Days, Sivas, Türkiye, 28 - 30 Eylül 2023, ss.245

  • Yayın Türü: Bildiri / Özet Bildiri
  • Basıldığı Şehir: Sivas
  • Basıldığı Ülke: Türkiye
  • Sayfa Sayıları: ss.245
  • Sivas Cumhuriyet Üniversitesi Adresli: Evet

Özet

CURRENT APPROVED TARGETED THERAPY DRUGS USED IN SPESIFIC CANCER TYPES

Today, it is critical to increase effective treatment options in order to reduce the death rate from cancer diseases. In addition to developing new drugs in increasing effective treatment options, studies on existing drugs and diversification of usage alternatives are among the researches. As a result of studies, targeted therapy drugs approved for use on specific cancer types are published by institutes of cancer [1-3]. Drug treatment in cancer diseases requires a relatively long time and high cost, so the need for health care’s services increases in long-term treatment of patients. Successful and cost-effective approaches to cancer treatments have been the subject of researches in recent years [4-6]. In this presentation, the current status of drugs approved for use for specific cancer types by the American Food and Drug Agency and their license status in Türkiye is going to be given on the basis of 2023. Pharmaceutical dosage forms and routes of administration of these drugs is also be going to be given, and the need for healthcare personnel in treatment is going to be evaluated.